Prolacta Bioscience appoints David Steinberg as chief financial officer
Type: Press Releases
Topic(s): Company
International Conference on Human Milk Science & Innovation to discuss latest research on bioactivity and neurodevelopment
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events Neurodevelopmental Outcomes Probiotics
Formula shortage response
Type: Blog
Topic(s): Company
Prolacta Bioscience salutes World Human Milk Donation Day, thanks donors who save fragile infant lives every day
Type: Press Releases
Topic(s): Donors
Study published in the journal Cell Host & Microbe offers proof of concept that a human milk-based synbiotic could allow therapeutic manipulation of the gut microbiome
Type: Press Releases
Topic(s): Clinical Studies Company Microbiome
Alecia-Jane Twigger, Ph.D., wins the Ruth A. Lawrence Investigator Award for outstanding contributions to advancing human milk science
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events
Independent, head-to-head study shows significant health benefits of early fortification associated with Prolacta Bioscience’s 100% human milk-based fortifiers compared to cow milk-based fortifiers for premature infants
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Early Fortification
Should human milk-based nutritional products for premature infants be homogenized? More research is needed, new journal article says
Type: Press Releases
Topic(s): Clinical Studies on Prolact/Humavant CR Company Pasteurization Product
The story of baby Eliza and Octavia, as told by their mom, Caytlin
Type: Parent Stories
Topic(s): 28-32 weeks (very premature) Parents
